Stephen Silvestro's Insider Trades & SAST Disclosures
Stephen Silvestro's most recent trade in OptimizeRx Corp was a trade of 1,928 Restricted Stock Units done . Disclosure was reported to the exchange on March 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stephen Silvestro.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 1,928 | 0 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 1,928 | 121,886 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.18 per share. | 01 Mar 2025 | 572 | 121,314 (0%) | 0% | 5.2 | 2,963 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.64 per share. | 15 Feb 2025 | 2,298 | 119,958 (0%) | 0% | 6.6 | 15,259 | Common Stock |
| OptimizeRx Corp | L. Silvestro Stephen | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 77,742 | 77,742 | - | - | Stock Option | |
| OptimizeRx Corp | L. Stephen Silvestro | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 41,408 | 122,256 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | L. Silvestro Stephen | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2024 | 6,546 | 83,424 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | L. Stephen Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2024 | 6,546 | 13,093 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.75 per share. | 19 Dec 2024 | 2,576 | 80,848 (0%) | 0% | 4.8 | 12,236 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 6,649 | 6,649 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2024 | 6,649 | 79,495 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.83 per share. | 03 Oct 2024 | 2,617 | 76,878 (0%) | 0% | 7.8 | 20,491 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 90,000 | 0 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 90,000 | 108,261 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.70 per share. | 02 May 2024 | 35,415 | 72,846 (0%) | 0% | 10.7 | 378,941 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 7,750 | 13,706 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 1,927 | 6,624 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 1,927 | 1,928 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 1,927 | 18,833 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.95 per share. | 01 Mar 2024 | 668 | 5,956 (0%) | 0% | 16.0 | 10,655 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.95 per share. | 01 Mar 2024 | 572 | 18,261 (0%) | 0% | 15.9 | 9,123 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 7,750 | 16,906 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2023 | 19,639 | 19,639 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Silvestro L. Stephen | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2023 | 19,639 | 19,639 | - | - | Stock Option | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2023 | 6,649 | 6,649 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2023 | 6,649 | 13,298 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.06 per share. | 03 Oct 2023 | 1,952 | 4,697 (0%) | 0% | 7.1 | 13,781 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,927 | 3,855 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,927 | 5,127 (0%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.11 per share. | 01 Mar 2023 | 668 | 4,459 (0%) | 0% | 18.1 | 12,097 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 39,055 | 39,055 | - | - | Stock Option | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 19,947 | 19,947 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Stephen L. Silvestro | CCO | Purchase of securities on an exchange or from another person at price $ 15.66 per share. | 16 Aug 2022 | 3,200 | 3,200 (0%) | 0% | 15.7 | 50,112 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 11,726 | 11,726 | - | - | Stock Option | |
| OptimizeRx Corp | Stephen L. Silvestro | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 5,782 | 5,782 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 85.38 per share. | 18 Oct 2021 | 13,241 | 0 (0%) | 0% | 85.4 | 1,130,517 | Common Stock pursuant to 10B5-1 plan |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2021 | 13,241 | 64,993 | - | - | Stock Option | |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 18 Oct 2021 | 13,241 | 13,241 (0%) | 0% | 7.5 | 99,440 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2021 | 13,242 | 78,234 | - | - | Stock Option | |
| OptimizeRx Corp | Stephen L. Silvestro | CCO | Sale of securities on an exchange or to another person at price $ 69.79 per share. | 17 Sep 2021 | 13,242 | 0 (0%) | 0% | 69.8 | 924,159 | Common Stock pursuant to 10B5-1 plan |
| OptimizeRx Corp | Stephen L. Silvestro | CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 17 Sep 2021 | 13,242 | 13,242 (0%) | 0% | 7.5 | 99,447 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 58.41 per share. | 17 Aug 2021 | 13,242 | 0 (0%) | 0% | 58.4 | 773,465 | Common Stock pursuant to 10B5-1 plan |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 13,242 | 91,476 | - | - | Stock Option | |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 17 Aug 2021 | 13,242 | 13,242 (0%) | 0% | 7.5 | 99,447 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 50.34 per share. | 20 Jul 2021 | 13,242 | 0 (0%) | 0% | 50.3 | 666,602 | Common Stock pursuant to 10B5-1 plan |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 20 Jul 2021 | 13,242 | 13,242 (0%) | 0% | 7.5 | 99,447 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2021 | 13,242 | 104,718 | - | - | Stock Option | |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 53.44 per share. | 17 Jun 2021 | 13,242 | 0 (0%) | 0% | 53.4 | 707,652 | Common Stock pursuant to 10B5-1 plan |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2021 | 13,242 | 117,960 | - | - | Stock Option | |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 17 Jun 2021 | 13,242 | 13,242 (0%) | 0% | 7.5 | 99,447 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 42.72 per share. | 17 May 2021 | 13,242 | 0 (0%) | 0% | 42.7 | 565,698 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2021 | 13,242 | 131,202 | - | - | Stock Option | |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.51 per share. | 17 May 2021 | 13,242 | 13,242 (0%) | 0% | 7.5 | 99,447 | Common Stock |
| OptimizeRx Corp | Stephen L. Silvestro | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 38,511 | 144,444 | - | - | Stock Option |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges